Potential therapeutic target for melanoma identifiedApril 16th, 2009 - 2:15 pm ICT by ANI
Washington, Apr 16 (ANI): Researchers at Albany Medical College claim to have identified a potential therapeutic target for melanoma.
The team led by Dr Andrew Aplin, an associate professor of Cancer Biology at Jefferson Medical College of Thomas Jefferson University, has discovered a protein called Mcl-1 that plays a critical role in melanoma cell resistance to a form of apoptosis called anoikis.
Mcl-1 is part of the Bcl-2 protein family, and is regulated by B-RAF proteins, which are mutated in approximately 60 percent of all human melanomas.
Aplin said that presence of Mcl-1 causes cell resistance to anoikis. This resistance to anoikis enables the melanoma cells to metastasize and survive at sites distant from the primary tumour.
During the study, the research team looked at three candidate Bcl-2 proteins: Mcl-1, Bcl-2 and Bcl-XL.
“When we depleted Mcl-1 from the tumour cells, they were susceptible to cell death,” said Aplin.
“Mcl-1 showed dramatic results compared to Bcl-2 and Bcl-XL, which was a surprise.
“Our findings show that targeting Mcl-1, which is upregulated in a majority of melanoma cells, could be a viable treatment strategy,” he added.
The study is published in Molecular Cancer Research. (ANI)
- New strategy to fight cancer drug resistance discovered - Jun 21, 2010
- New hope in the fight against melanoma - Dec 14, 2010
- Compound boosts cancer-killing properties of agent in trials - Jun 10, 2010
- Melanoma spreads to lungs using body's immune system - Oct 08, 2010
- Zebrafish offers skin cancer clues - Apr 06, 2011
- Zebrafish model reveals skin cancer-promoting gene - Mar 24, 2011
- How melanoma tumours evade drug treatment - Nov 25, 2010
- Scientists complete whole-exome sequencing of skin cancer - Apr 16, 2011
- New hope for cancer cure - Jul 08, 2011
- Novel peptide 'kills' cancer cells more effective than current therapies - Jan 23, 2011
- How 'self-eating' cells safeguard against cancer - Feb 26, 2011
- Targeting protein helps keep melanoma tumour growth in check - Dec 10, 2010
- New drug type developed to kill lymphoma cells - May 11, 2010
- Stress can make tumours grow bigger - Apr 13, 2010
- Skin cancer pill showing 'remarkable' results, say researchers - Aug 26, 2010
Tags: albany medical college, anoikis, bcl 2, cancer biology, cancer research, cell death, dr andrew, dramatic results, jefferson medical college, jefferson medical college of thomas jefferson universit, melanoma, melanoma cells, melanomas, molecular cancer, protein family, therapeutic target, thomas jefferson university, treatment strategy, tumour cells, viable treatment